Nederman Holding AB
F:5QR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nederman Holding AB
F:5QR
|
SE |
|
N
|
Nirlon Ltd
BSE:500307
|
IN |
|
I
|
Intesa Sanpaolo SpA
XHAM:IES
|
IT |
|
E
|
Evertec Inc
XMUN:2EV
|
PR |
|
D
|
Dolby Laboratories Inc
XMUN:FUO
|
US |
|
WuXi Biologics (Cayman) Inc
F:1FW2
|
CN |
|
Merus NV
NASDAQ:MRUS
|
NL |
|
Dave Inc
NASDAQ:DAVE
|
US |
Wall St Price Targets
5QR Price Targets Summary
Nederman Holding AB
According to Wall Street analysts, the average 1-year price target for 5QR is 20.1 EUR with a low forecast of 18.99 EUR and a high forecast of 21.64 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5QR's stock price target?
Price Target
20.1
EUR
According to Wall Street analysts, the average 1-year price target for 5QR is 20.1 EUR with a low forecast of 18.99 EUR and a high forecast of 21.64 EUR.
What is the Revenue forecast for Nederman Holding AB?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Nederman Holding AB?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Nederman Holding AB?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 11%.
